INHALATION SCIENCES SWEDEN AB (Stockholm, Sweden, 12 January 2023) Post your questions to ISAB CEO Manoush Masarrat and Chairman Daniel Spasic for their joint Redeye event on March 6[th], 2023. The pair will take investor's questions on 2022's development and milestones, and how ISAB will keep growing momentum in 2023. Please submit your questions by February 27[th], 2023.
At 10.00 CET Match 6th 2023, ISAB CEO Manoush Masarrat and Chairman Daniel Spasic will present Inhalation Sciences' 2022 company update and outlook for 2023. They will provide strategic and operational perspectives on ISAB's development and milestones in 2022 and present the company's main priorities moving forward.
The company welcomes questions from its shareholders ahead of the presentation.
Questions should be submitted by February 27th, 2023, at the latest.
Please submit your questions to:
Gustaf Meyer:gustaf.meyer@redeye.se
or
Manoush Masarrat:manoush.masarrat@inhalation.se
For more information about Inhalation Sciences, please contact: Manoush Masarrat, CEO E-mail: Manoush.masarrat@inhalation.se Mobile: +46 (0)73 628 9153
Press release in PDF formatAttachments
- Original Link
- Original Document
- Permalink
Disclaimer
Inhalation Sciences Sweden AB published this content on 12 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 January 2023 09:49:00 UTC.
